BioCentury
ARTICLE | Clinical News

ChemoFx Assay diagnostic data

March 3, 2014 8:00 AM UTC

An observational study in 276 patients with stage III/IV ovarian, fallopian or peritoneal cancer who received first-line therapy of carboplatin and paclitaxel showed that median PFS was significantly ...